SeaStar Medical Holding Corp (ICUCW)
Based in Denver, Colorado, SeaStar Medical Holding Corporation operates as a medical device company. Its primary mission is to develop innovative therapies and services designed to combat hyperinflammation and cytokine storm, particularly in critically ill individuals. The company specializes in advancing and bringing to market extracorporeal treatments. These therapies are engineered to specifically target the immune "effector cells" that fuel widespread systemic inflammation, which is known to cause direct tissue damage and unleash a cascade of pro-inflammatory cytokines, leading to dysregulated immune responses. SeaStar Medical's product pipeline extends across diverse therapeutic domains. These include both pediatric and adult acute kidney injury, particularly when patients are undergoing continuous renal replacement therapy (CRRT); cardiorenal syndrome observed in cases of congestive heart failure, whether or not an LVAD is present; myocardial stunning associated with end-stage renal disease; and hepatorenal syndrome.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Biotechnology
SeaStar Medical Holding Corporation
-20.59%$0.0108
CLOSED · Nov 5Prev close$0.0136-20.59%Close$0.0108
Mkt Cap$57K
Float-
O/S5.26M
VOL14K sh
$ Vol$206
RVOL0.47×
Inst Own-
EarningsNov 12 · in 3d
Dilution
Financials Summary
Revenue$1.23M
Net Income-$12.15M
Total Assets$14.16M
Free Cash Flow-$13.6M
Debt & Equity
Debt 5%
Equity 95%
Total Debt$525K
Total Equity$10.42M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ICUCW's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$14.16M
Liabilities$3.74M
Accounts Receivable$237K
Accounts Payable$948K
Inventory$66K
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | $1.23M | $135K | $0 | $0 | $0 | $0 |
| YoY Growth | 814.1% | - | - | - | - | - |
| Cost of Revenue | $53K | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $1.18M | $135K | $0 | $0 | $0 | $0 |
| Gross Margin | 95.7% | 100.0% | - | - | - | - |
| Research and Development | $7.52M | $9.11M | $5.97M | $2.5M | $2.77M | $4.03M |
| Selling, General, and Administrative | $5.84M | $8.87M | $8.04M | $6.92M | $1.68M | $2.43M |
| Other | $0 | $0 | $200K | $2.19M | $0 | $0 |
| Total Operating Expenses | $13.36M | $17.98M | $14.21M | $11.61M | $4.45M | $6.45M |
| Operating Income (EBIT) | -$12.18M | -$17.84M | -$14.21M | -$11.61M | -$4.45M | -$6.45M |
| Operating Margin | -986.6% | -13216.3% | - | - | - | - |
| Interest Expense | $329K | $244K | $1.08M | $630K | $212K | $3.31M |
| Interest Income | $325K | $101K | $0 | $630 | $0 | $0 |
| Other Income (Expense) | $28K | -$6.99M | -$12.02M | -$580K | -$148K | $3.19M |
| Income Before Tax (EBT) | -$12.15M | -$24.83M | -$26.23M | -$12.19M | -$4.6M | -$3.27M |
| Income Tax Expense | $3K | $3K | $0 | $1K | -$1K | $9K |
| Net Income | -$12.15M | -$24.83M | -$26.23M | -$12.19M | -$4.6M | -$3.28M |
| Net Income Margin | -984.6% | -18392.6% | - | - | - | - |
| Supplementary Data | ||||||
| EPS | -5.86 | -66.30 | -302.62 | -233.80 | -88.10 | -0.10 |
| Diluted EPS | -5.86 | -66.30 | -302.62 | -233.80 | -88.10 | -0.10 |
| Weighted Average OS | 20.73M | 374,400 | 86,681 | 52,132 | 52,164 | 52,164 |
| EBITDA | -$12.16M | -$24.58M | -$11.14M | -$11.56M | -$4.38M | $0 |
| EBITDA Margin | -985.2% | -18209.6% | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $11.98M | $1.82M | $176K | $47K | $510K | $2.81M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $11.98M | $1.82M | $176K | $47K | $510K | $2.81M |
| Accounts Receivable | $237K | $112K | $0 | $0 | $58K | $0 |
| Inventory | $66K | $0 | $0 | $0 | $0 | $55K |
| Other Current Assets | $0 | $0 | $0 | $12K | $0 | $0 |
| Total Current Assets | $13.58M | $3.77M | $2.31M | $1.52M | $601K | $2.91M |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $578K | $892K | $1.21M | $1.52M | $2K | $2K |
| Total Long-Term Assets | $578K | $892K | $1.21M | $1.52M | $2K | $2K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $14.16M | $4.66M | $3.51M | $3.04M | $603K | $2.91M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $948K | $3.05M | $4.37M | $1.93M | $85K | $382K |
| Short-Term Debt | $525K | $574K | $4.74M | $1.18M | $2.38M | $20K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1K | $33K | $2.41M | $10.8M | $471K | $0 |
| Total Current Liabilities | $3.74M | $6.84M | $13.05M | $16.15M | $3.12M | $1.08M |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $0 | $0 | $4.34M | $7.65M | $244K | $63K |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $55K | $73.35M |
| Total Long-Term Liabilities | $0 | $0 | $4.34M | $7.65M | $299K | $73.41M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3.74M | $6.84M | $17.38M | $23.8M | $3.42M | $74.49M |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $4K | $2K | $5K | $1K | $1K | $0 |
| Retained Earnings | -$151.71M | -$139.56M | -$114.73M | -$88.5M | -$76.31M | -$71.72M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $162.13M | $137.38M | $100.86M | $67.74M | $73.5M | $133K |
| Total Equity | $10.42M | -$2.18M | -$13.87M | -$20.76M | -$2.82M | -$71.58M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $14.16M | $4.66M | $3.51M | $3.04M | $603K | $2.91M |
| Supplementary Data | ||||||
| Total Debt | $525K | $574K | $9.08M | $8.83M | $2.62M | $83K |
| Net Debt | -$11.46M | -$1.25M | $8.9M | $8.78M | $2.11M | -$2.72M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Operating Activities | ||||||
| Net Income | -$12.15M | -$24.83M | -$26.23M | -$12.19M | -$4.6M | -$3.28M |
| Depreciation & Amortization | $18K | $0 | $14.01M | $0 | $0 | $6.45M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $624K | $887K | $1.93M | $1.31M | $14K | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | -$125K | -$112K | $12K | $4K | $0 | $0 |
| Inventory | -$66K | $0 | $0 | $0 | $55K | $137K |
| Accounts Payable | -$2.1M | -$1.28M | $2.44M | $1.55M | -$297K | $225K |
| Other Working Capital | -$68K | $2.38M | $420K | $1M | -$438K | $528K |
| Total Working Capital Change | -$2.36M | $992K | $2.88M | $2.55M | -$680K | $890K |
| Other Non-Cash Items | $266K | $6.94M | -$2.87M | $533K | $148K | -$9.64M |
| Net Cash from Operating | -$13.6M | -$16.01M | -$10.29M | -$7.79M | -$5.11M | -$5.57M |
| Investing Activities | ||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$105.57M | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $105.57M | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | ||||||
| Debt Repaid | $67K | $4.41M | -$3.53M | -$3.48M | -$2.82M | $133K |
| Common Stock Issuance | $23.83M | $17.44M | $6.61M | $10M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $4.62M | $272K | -$6.15M | $0 | $0 |
| Net Cash from Financing | $23.76M | $17.65M | $10.41M | $7.33M | $2.82M | $4.89M |
| Forex Effect | $0 | $0 | $0 | $0 | $2.77M | $0 |
| Net Change in Cash | $10.16M | $1.64M | $129K | -$463K | $472K | -$680K |
| Supplementary Data | ||||||
| Operating Cash Flow | -$13.6M | -$16.01M | -$10.29M | -$7.79M | -$5.11M | -$5.57M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$13.6M | -$16.01M | -$10.29M | -$7.79M | -$5.11M | -$5.57M |
| Cash at Beginning | $1.82M | $176K | $47K | $510K | $38K | $3.49M |
| Cash at End | $11.98M | $1.82M | $176K | $47K | $510K | $2.81M |